1. Home
  2. LUCY vs ARTL Comparison

LUCY vs ARTL Comparison

Compare LUCY & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCY
  • ARTL
  • Stock Information
  • Founded
  • LUCY 2017
  • ARTL 2011
  • Country
  • LUCY United States
  • ARTL United States
  • Employees
  • LUCY N/A
  • ARTL N/A
  • Industry
  • LUCY Ophthalmic Goods
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUCY Health Care
  • ARTL Health Care
  • Exchange
  • LUCY Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • LUCY 8.7M
  • ARTL 7.0M
  • IPO Year
  • LUCY 2022
  • ARTL N/A
  • Fundamental
  • Price
  • LUCY $1.92
  • ARTL $5.57
  • Analyst Decision
  • LUCY
  • ARTL Buy
  • Analyst Count
  • LUCY 0
  • ARTL 2
  • Target Price
  • LUCY N/A
  • ARTL $30.00
  • AVG Volume (30 Days)
  • LUCY 194.2K
  • ARTL 129.8K
  • Earning Date
  • LUCY 11-11-2025
  • ARTL 11-11-2025
  • Dividend Yield
  • LUCY N/A
  • ARTL N/A
  • EPS Growth
  • LUCY N/A
  • ARTL N/A
  • EPS
  • LUCY N/A
  • ARTL N/A
  • Revenue
  • LUCY $1,978,018.00
  • ARTL N/A
  • Revenue This Year
  • LUCY $149.32
  • ARTL N/A
  • Revenue Next Year
  • LUCY $400.00
  • ARTL N/A
  • P/E Ratio
  • LUCY N/A
  • ARTL N/A
  • Revenue Growth
  • LUCY 29.30
  • ARTL N/A
  • 52 Week Low
  • LUCY $1.57
  • ARTL $4.20
  • 52 Week High
  • LUCY $11.16
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • LUCY 47.74
  • ARTL 37.10
  • Support Level
  • LUCY $1.82
  • ARTL $4.60
  • Resistance Level
  • LUCY $1.98
  • ARTL $5.53
  • Average True Range (ATR)
  • LUCY 0.10
  • ARTL 0.58
  • MACD
  • LUCY 0.01
  • ARTL 0.04
  • Stochastic Oscillator
  • LUCY 51.22
  • ARTL 26.45

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: